XML 25 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Class A Common Stock
Common stock
Class A Common Stock
Common stock
Class B Common Stock
Additional Pain-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2023     94,655,000 56,489,000        
Stockholders' Equity, beginning balance at Jan. 31, 2023 $ 814,501   $ 0 $ 0 $ 1,497,373 $ (735,611) $ (827) $ 53,566
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Conversion of stock (in shares)     16,995,000 (16,995,000)        
Issuance of common stock related to vested exercised stock options (in shares)       3,406,000        
Issuance of common stock related to vested exercised stock options 32,448       32,448      
Issuance of common stock under employee stock purchase plan (in shares)     417,000          
Issuance of common stock under employee stock purchase plan 12,933       12,933      
Repurchases, net of early exercised stock options (in shares)       (13,000)        
Issuance of common stock related to RSUs and PSUs vested (in shares)     2,372,000          
Charitable donation of common stock (in shares)   231,408 231,000          
Charitable donation of common stock 10,700 $ 10,700     10,700      
Vesting of early exercised stock options 1,234       1,234      
Stock-based compensation expense 163,049       164,515     (1,466)
Change in noncontrolling interest ownership 0       (542)     542
Other comprehensive income (loss) 1,063           3,225 (2,162)
Net loss (429,536)         (425,677)   (3,859)
Stockholders' Equity, ending balance (in shares) at Jan. 31, 2024     114,670,000 42,887,000        
Stockholders' Equity, ending balance at Jan. 31, 2024 606,392   $ 0 $ 0 1,718,661 (1,161,288) 2,398 46,621
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Conversion of stock (in shares)     25,933,000 (25,933,000)        
Issuance of common stock in connection with business combination, net (in shares)       27,000        
Issuance of common stock related to vested exercised stock options (in shares)       2,488,000        
Issuance of common stock related to vested exercised stock options 23,973       23,973      
Issuance of common stock under employee stock purchase plan (in shares)     420,000          
Issuance of common stock under employee stock purchase plan 13,556       13,556      
Issuance of common stock related to RSUs and PSUs vested (in shares)     3,200,000          
Charitable donation of common stock (in shares)   221,195 221,000          
Charitable donation of common stock 11,827 $ 11,800     11,827      
Vesting of early exercised stock options 341       341      
Stock-based compensation expense 185,899       184,086     1,813
Change in noncontrolling interest ownership 0       (413)     413
Other comprehensive income (loss) (11,563)           (10,906) (657)
Net loss (9,119)         (6,326)   (2,793)
Stockholders' Equity, ending balance (in shares) at Jan. 31, 2025     144,444,000 19,469,000        
Stockholders' Equity, ending balance at Jan. 31, 2025 $ 821,306 [1]   $ 0 $ 0 1,952,031 (1,167,614) (8,508) 45,397
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Conversion of stock (in shares)     4,573,000 (4,580,000)        
Issuance of common stock related to vested exercised stock options (in shares) 1,844,000     1,844,000        
Issuance of common stock related to vested exercised stock options $ 21,795       21,795      
Issuance of common stock under employee stock purchase plan (in shares)     415,000          
Issuance of common stock under employee stock purchase plan 13,975       13,975      
Repurchases, net of early exercised stock options (in shares)       (1,000)        
Issuance of common stock related to RSUs and PSUs vested (in shares)     3,761,000          
Common stock withheld related to net share settlement of equity awards (in shares)     (21,000)          
Common stock withheld related to net share settlement of equity awards (945)       (945)      
Charitable donation of common stock (in shares)   163,555 164,000          
Charitable donation of common stock 7,093 $ 7,100     7,093      
Vesting of early exercised stock options 56       56      
Stock-based compensation expense 215,517       213,264     2,253
Change in noncontrolling interest ownership 0       92     (92)
Other comprehensive income (loss) 16,015           15,385 630
Net loss (58,564)         (55,956)   (2,608)
Stockholders' Equity, ending balance (in shares) at Jan. 31, 2026     153,336,000 16,732,000        
Stockholders' Equity, ending balance at Jan. 31, 2026 $ 1,036,248 [1]   $ 0 $ 0 $ 2,207,361 $ (1,223,570) $ 6,877 $ 45,580
[1]
(1) As of January 31, 2026 and January 31, 2025, the consolidated balance sheets include assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $41.0 million and $46.5 million, respectively, and liabilities of $7.1 million and $10.3 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.